Back to search

Article

Passenger mutations as a target for the personalized therapy of cancer

2018-11-11

Abstract excerpt

The American FDA approved the first comprehensive NGS diagnostic assay for cancer at the end of 2017, leading the way to personalised therapy of cancer and the massive employ of bioinformatics (https://www.fda.gov/downloads/medicaldevices/productsandmedicalprocedures/invitrodiagnostics/ ucm584603.pdf ). In NGS-detected genes from cancer patients, driver and passenger mutations can be distinguished. The former prov...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
634a5772-d50d-5e1b-bf46-a06ff0f0618f
DOI
10.7287/peerj.preprints.27338v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Passenger mutations as a target for the personalized therapy of cancerDOI 10.7287/peerj.preprints.27338v1
Select a neighboring publication to make it the new centre.